ArticleFrontiers in oncology2017

Selective Targeting of the L858R Mutation (EGFR) in Non-Small Cell Lung Cancer: A Mechanism for Advancing Targeted Chemotherapy.

Rohan Arora et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.